Mohamed earned the scholarship after presenting his research on the effects of Alzheimer’s disease.
Mohamed’s project, titled “Donepezil and rivastigmine enhance brain and hepatic clearances of amyloid: a novel mechanism for their neuroprotective effect against Alzheimer’s disease,” was presented at the 9th Annual Drug Discovery for Neurodegeneration Conference, in San Diego, Calif., in March.
Mohamed is advised by Dr. Amal Kaddoumi, associate professor of pharmaceutics.
The scholarship provides registration to attend the annual conference; the opportunity to present at the annual conference; and recognition in the conference program and on the ADDF website.